Log in
E-mail
Password
Show password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
New member
Sign up for FREE
New customer
Discover our services
Settings
Settings
Dynamic quotes 
OFFON
  1. Homepage
  2. Equities
  3. Japan
  4. Japan Exchange
  5. FUJIFILM Holdings Corporation
  6. News
  7. Summary
    4901   JP3814000000

FUJIFILM HOLDINGS CORPORATION

(4901)
  Report
SummaryChartsNewsRatingsCalendarCompanyFinancialsConsensusRevisions 
SummaryMost relevantAll NewsOther languagesPress ReleasesOfficial PublicationsSector newsMarketScreener Strategies

FUJIFILM : Japan's Fujifilm to make coronavirus antigen testing kits in Vietnam

12/20/2020 | 11:48pm EDT

Japanese precision chemistry firm Fujifilm Corp. will make novel coronavirus antigen testing kits in Vietnam for global markets by expanding its local production facilities.

Fujifilm will invest an undisclosed amount in Fujifilm Yuwa Medical Products Vietnam Co., a joint venture producing diagnostic agents, in stages starting in the next fiscal year to build a monthly production capacity of 2 million testing kits, an official of the Tokyo-based company said Thursday. A date for the start of production there has yet to be decided.

With its own technology used in the photo printing process, the kits can quickly and easily detect the novel coronavirus antigens. In Japan, Fujifilm plans to produce the kits at its plant in Kanagawa Prefecture, west of Tokyo, as it has applied for manufacturing and marketing approval to the state's examining authority, the company said in a statement.

Fujifilm Yuwa Medical Products was established in May in Binh Duong Province, southern Vietnam, with Fujifilm owning 51 percent and Yuwa Co., a molding maker based in Nagano Prefecture, 49 percent and started producing diagnostic drugs in November, according to the statement.

In antigen tests, doctors insert swabs into a patient's nostril and put nasal discharge on a testing kit plate to get the result on site. Despite its lower accuracy than the currently dominant polymerase chain reaction, or PCR, tests, the quick and easy method is expected to be used in airports and event venues as well as hospitals, with demand likely to grow. (NNA/Kyodo)

==Kyodo

© Kyodo News International, Inc., source Newswire

All news about FUJIFILM HOLDINGS CORPORATION
09/22FUJIFILM : The premium compact digital camera “FUJIFILM X100V” wins Bronze Awa..
PU
09/21APPILI THERAPEUTICS : Announces Agreement with FUJIFILM and Funding Support for Clinical T..
AQ
09/21FUJIFILM : Two Fujifilm Leaders Recognized as “Women Worth Watching” by Profil..
AQ
09/21FUJIFILM : North America Corporation Celebrates Newest FUJIFILM Creators
AQ
09/20APPILI THERAPEUTICS : Up 1% as Secures US$1 Million from FUJIFILM to Support Clinical Tria..
MT
09/20APPILI THERAPEUTICS : Secures US$1 Million from FUJIFILM to Support Clinical Trials for An..
MT
09/06FUJIFILM : Launches LTO Ultrium9 Data Cartridge -Magnetic tape storage media with maximum ..
PU
09/02Peptidream to Acquire Fujifilm Toyama Chemical's Radiopharmaceutical Business
MT
09/02FUJIFILM : launches FUJINON Lens GF35-70mmF4.5-5.6 WRá(Fujifilm)
PU
09/02FUJIFILM : launches mirrorless digital camera “FUJIFILM GFX50S II”á(Fujifilm)
PU
More news
Financials
Sales 2022 2 499 B 22 673 M 22 673 M
Net income 2022 172 B 1 565 M 1 565 M
Net Debt 2022 228 B 2 072 M 2 072 M
P/E ratio 2022 22,2x
Yield 2022 1,11%
Capitalization 3 839 B 35 038 M 34 839 M
EV / Sales 2022 1,63x
EV / Sales 2023 1,57x
Nbr of Employees 73 275
Free-Float 73,9%
Chart FUJIFILM HOLDINGS CORPORATION
Duration : Period :
FUJIFILM Holdings Corporation Technical Analysis Chart | 4901 | JP3814000000 | MarketScreener
Technical analysis trends FUJIFILM HOLDINGS CORPORATION
Short TermMid-TermLong Term
TrendsBullishBullishBullish
Income Statement Evolution
Consensus
Sell
Buy
Mean consensus BUY
Number of Analysts 14
Last Close Price 9 603,00 JPY
Average target price 10 057,14 JPY
Spread / Average Target 4,73%
EPS Revisions
Managers and Directors
Teiichi Goto President, CEO & Representative Director
Kenji Sukeno Chairman
Takashi Iwasaki Director & Chief Technology Officer
Kunitaro Kitamura Independent Outside Director
Tatsuo Kawada Independent Outside Director
Sector and Competitors
1st jan.Capi. (M$)
FUJIFILM HOLDINGS CORPORATION76.59%35 038
ABBOTT LABORATORIES13.85%220 982
MEDTRONIC PLC10.05%173 488
BECTON, DICKINSON AND COMPANY2.63%73 750
HOYA CORPORATION28.03%61 504
SARTORIUS STEDIM BIOTECH80.15%56 765